Patents by Inventor Jianliang Lu

Jianliang Lu has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • NOVEL MCH RECEPTOR ANTAGONISTS
    Publication number: 20090093456
    Abstract: The present invention relates to a melanin concentrating hormone antagonist compound of formula (1): wherein R1, Ra, Rb, R2, L1, R3, R4 and R5 are as defined, or a pharmaceutically acceptable salt, enantiomer, diastereomer or mixture of diasteromers thereof useful in the treatment, obesity and related diseases.
    Type: Application
    Filed: June 8, 2007
    Publication date: April 9, 2009
    Inventors: Macklin Brian Arnold, Yen Dao, Kevin Matthew Gardinier, David Joseph Garmene, Steven James Green, Erik James Hembre, Jianliang Lu
  • Vitamin D Receptor Modulators
    Publication number: 20090018058
    Abstract: The present invention relates to novel, non-secosteroidal, diaryl compounds with vitamin D receptor (VDR) modulating and psoriasis.
    Type: Application
    Filed: November 20, 2003
    Publication date: January 15, 2009
    Applicant: ELI LILLY AND COMPANY
    Inventors: Emilio Enrique Bunel, Robert Peter Gajewski, Charles David Jones, Jianliang Lu, Tianwei Ma, Sunil Nagpal, Ying Kwong Yee
  • Phenyl-furan compounds as vitamin D receptor modulators
    Patent number: 7468449
    Abstract: The present invention relates to novel, non-secosteroidal, phenyl-furan compounds with vitamin D receptor (VDR) modulating activity that are less hypercalcemic than 1?,25dihydroxy vitamin D3. These compounds are useful for treating bone disease and psoriasis.
    Type: Grant
    Filed: November 16, 2004
    Date of Patent: December 23, 2008
    Assignee: Eli Lilly and Company
    Inventors: Robert Peter Gajewski, Charles David Jones, Jianliang Lu, Tianwei Ma, Sunil Nagpal, Ying Kwong Yee
  • Vitamin D Receptor Modulators
    Publication number: 20080200552
    Abstract: The present invention relates to novel, non-secosteroidal, hydroxyl substituted, carbon-linked diaryl compounds with vitamin D receptor (VDR) modulating activity that are less hypercalcemic than 1?,25 dihydroxy vitamin D3. These compounds are useful for treating bone disease and psoriasis.
    Type: Application
    Filed: November 16, 2004
    Publication date: August 21, 2008
    Applicant: ELI LILLY AND COMPANY
    Inventors: Emilio Enrique Bunel, Robert Peter Gajewski, Charles David Jones, Jianliang Lu, Sunil Nagpal, Tianwei Ma, Ying Kwong Yee
  • Imidazopyridazine Compounds
    Publication number: 20080153828
    Abstract: The present invention relates to novel substituted imidazo[1,2-b]pyridazine compounds of Formula (I) pharmaceutical compositions thereof, and the use such compounds as corticotropin releasing factor 1 (CRF1) receptor antagonists in the treatment of psychiatric disorders and neurological diseases.
    Type: Application
    Filed: April 3, 2006
    Publication date: June 26, 2008
    Inventors: Elizabeth Aaron Collins, Pablo Garcia-Losada, Chafiq Hamdouchi, Philip Arthur Hipskind, Jianliang Lu, Takako Takakuwa
  • Imidazopyridazine Compounds
    Publication number: 20080113978
    Abstract: The present invention relates to novel substituted imidazo[1,2-b]pyridazine compounds of Formula (I): pharmaceutical compositions thereof, and the use such compounds as corticotropin releasing factor 1 (CRF1) receptor antagonists in the treatment of psychiatric disorders and neurological diseases.
    Type: Application
    Filed: March 20, 2006
    Publication date: May 15, 2008
    Inventors: Heather Janelle Barbosa, Elizabeth Aaron Collins, Chafip Hamdouchi, Erik James Hembre, Philip Arthur Hipskind, Richard Duane Johnston, Jianliang Lu, Michael John Rupp, Takako Takakuwa, Richard Craig Thompson
  • Vitamin d receptor modulators
    Publication number: 20070149810
    Abstract: The present invention relates to novel, non-secosteroidal, phenyl-benzothiophene compounds with vitamin D receptor (VDR) modulating activity that are less hypercalcemic than 1?,25 dihydroxy vitamin D3. These compounds are useful for treating bone disease and psoriasis.
    Type: Application
    Filed: November 16, 2004
    Publication date: June 28, 2007
    Applicant: ELI LILLY AND COMPANY
    Inventors: Jianliang Lu, Tainwei Ma, Sunil Nagpal, Quanrong Shen, Alan Warshawsky, Ying Yee, Michael Rupp
  • Vitamin d receptor modulators
    Publication number: 20070106095
    Abstract: The present invention relates to novel, non-secosteroidal, phenyl-benzofuran compounds with vitamin D receptor (VDR) modulating activity that are less hypercalcemic than 1?,25 dihydroxy vitamin D3. These compounds are useful for treating bone disease and psoriasis.
    Type: Application
    Filed: November 16, 2004
    Publication date: May 10, 2007
    Inventors: Jianliang Lu, Tianwei Ma, Sunil Nagpal, Quanrong Shen, Alan Warshawsky, Jason Ochoada, Ying Yee
  • Phenyl-furan compounds as vitamin d receptor modulators
    Publication number: 20070105951
    Abstract: The present invention relates to novel, non-secosteroidal, phenyl-furan compounds with vitamin D receptor (VDR) modulating activity that are less hypercalcemic than 1?,25dihydroxy vitamin D3. These compounds are useful for treating bone disease and psoriasis.
    Type: Application
    Filed: November 16, 2004
    Publication date: May 10, 2007
    Inventors: Robert Gajewski, Charles Jones, Jianliang Lu, Tianwei Ma, Sunil Nagpal, Ying Yee
  • Vitamin d receptor modulators
    Publication number: 20060293385
    Abstract: The present invention relates to novel, non-secosteroidal, sulfonate and sulfonamide functional diaryl compounds with vitamin D receptor (VDR) modulating activity that are less hypercalcemic than 1?,25 dihydroxy vitamin D3. These compounds are useful for treating bone disease and psoriasis.
    Type: Application
    Filed: November 8, 2004
    Publication date: December 28, 2006
    Inventors: Robert Gajewski, Charles Jones, Jared Linebarger, Jianliang Lu, Tianwei Ma, Sunil Nagpal, Ying Yee
  • Phenyl-thiophene type vitamin d receptor modulators
    Publication number: 20060287536
    Abstract: The present invention relates to novel, non-secosteroidal, phenyl-thiophene compounds with vitamin D receptor (VDR) modulating activity that are less hypercalcemic than 1?,25 dihydroxy vitamin D3. These compounds are useful for treating bone disease and psoriasis.
    Type: Application
    Filed: May 22, 2003
    Publication date: December 21, 2006
    Inventors: Karl Dahnke, Robert Gajewski, Charles Jones, Jared Linebarger, Jianliang Lu, Tianwei Ma, Sunil Nagpal, Todd Simard, Ying Yee, Emilio Bunel, Ryan Stites